Indonesian Hospital Shows How to Track Rare Diseases

When you're one of 45 million people in Southeast Asia with a rare disease, getting diagnosed can feel impossible. But a hospital in Indonesia just proved there's a faster way forward.

Dr Sardjito General Hospital in Yogyakarta became Indonesia's national rare disease hub in just two years. The hospital now tracks patients, manages data, and coordinates care for a country of 280 million people.

The secret wasn't fancy technology or unlimited funding. Dr Gunadi, who coordinates the rare disease hub, says collaboration made the difference. Clinicians provided patient data while researchers brought genetic testing expertise. Government agencies ensured policy support, and patient groups promoted awareness.

Indonesia's Biomedical and Genome Science Initiative gave the hospital infrastructure for systematic data collection. This framework helped overcome challenges like fragmented information, limited genetic testing access, and staff shortages.

Saida Abu Bakar, who heads the Dystrophic Epidermolysis Bullosa Research Association Malaysia, believes her country can follow this example. Malaysia faces the same obstacles Indonesia did, with about 12,000 patients across nearly 500 types of rare diseases currently in treatment.

"The Indonesian hospital's experience is useful not as a model to copy, but as an example of how rare disease data, genomics, clinical care and patient advocacy can be integrated," Saida said.

Malaysia's health ministry announced plans for a national rare disease registry in February. Health Minister Dzulkefly Ahmad promised to prioritize development and improve financing for treatment.

The Ripple Effect

Every year without comprehensive data leaves more patients undiagnosed and more families without support. Policy decisions get made without understanding the full picture of need.

But registries do more than count patients. They connect people to clinical trials, help researchers understand disease patterns, and show governments where resources matter most. When rare disease patients become visible in data, they become harder to ignore in healthcare planning.

Dr Gunadi recommends Malaysia establish clear governance, use standardized medical terminology, and identify specific centers for data collection. These building blocks create registries that last beyond initial enthusiasm.

The Indonesian success shows that countries don't need perfect conditions to start helping people. They need commitment, coordination, and urgency. For thousands of Malaysian families waiting for answers, that timeline of two years offers real hope.

#